GB0519923D0 - Interleukin-13 antibody composition - Google Patents

Interleukin-13 antibody composition

Info

Publication number
GB0519923D0
GB0519923D0 GBGB0519923.7A GB0519923A GB0519923D0 GB 0519923 D0 GB0519923 D0 GB 0519923D0 GB 0519923 A GB0519923 A GB 0519923A GB 0519923 D0 GB0519923 D0 GB 0519923D0
Authority
GB
United Kingdom
Prior art keywords
interleukin
antibody composition
antibody
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0519923.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune Ltd
Original Assignee
Cambridge Antibody Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Antibody Technology Ltd filed Critical Cambridge Antibody Technology Ltd
Priority to GBGB0519923.7A priority Critical patent/GB0519923D0/en
Publication of GB0519923D0 publication Critical patent/GB0519923D0/en
Priority to DK06794604.6T priority patent/DK1942939T4/en
Priority to CNA2006800449739A priority patent/CN101321540A/en
Priority to CN 201010551201 priority patent/CN102060925B/en
Priority to EP06794604.6A priority patent/EP1942939B2/en
Priority to KR1020087010374A priority patent/KR101363777B1/en
Priority to PCT/GB2006/003650 priority patent/WO2007036745A2/en
Priority to CN201410602375.5A priority patent/CN104667275B/en
Priority to JP2008532878A priority patent/JP2009510046A/en
Priority to BRPI0616359A priority patent/BRPI0616359B8/en
Priority to SI200632277T priority patent/SI1942939T2/en
Priority to HUE06794604A priority patent/HUE039022T2/en
Priority to US12/067,120 priority patent/US20080248048A1/en
Priority to NZ566694A priority patent/NZ566694A/en
Priority to PL06794604T priority patent/PL1942939T5/en
Priority to AU2006296399A priority patent/AU2006296399B2/en
Priority to PT06794604T priority patent/PT1942939T/en
Priority to LTEP06794604.6T priority patent/LT1942939T/en
Priority to ES06794604T priority patent/ES2685440T5/en
Priority to GB0619204A priority patent/GB2430883B/en
Priority to CA2623429A priority patent/CA2623429C/en
Priority to IL189983A priority patent/IL189983A/en
Priority to ZA200802413A priority patent/ZA200802413B/en
Priority to NO20081946A priority patent/NO344859B1/en
Priority to US12/966,377 priority patent/US9107945B2/en
Priority to JP2013212846A priority patent/JP5820450B2/en
Priority to IL230005A priority patent/IL230005A/en
Priority to US14/798,685 priority patent/US10358488B2/en
Priority to HK15111703.8A priority patent/HK1210724A1/en
Priority to IL246674A priority patent/IL246674B/en
Priority to CY181100758T priority patent/CY1120874T1/en
Priority to NL301143C priority patent/NL301143I2/en
Priority to NO2021050C priority patent/NO2021050I1/en
Priority to FR21C1055C priority patent/FR21C1055I2/en
Priority to LTPA2021528C priority patent/LTPA2021528I1/lt
Priority to FIC20210042C priority patent/FIC20210042I1/en
Priority to HUS2100053C priority patent/HUS2100053I1/en
Ceased legal-status Critical Current

Links

GBGB0519923.7A 2005-09-30 2005-09-30 Interleukin-13 antibody composition Ceased GB0519923D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GBGB0519923.7A GB0519923D0 (en) 2005-09-30 2005-09-30 Interleukin-13 antibody composition
CNA2006800449739A CN101321540A (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
ES06794604T ES2685440T5 (en) 2005-09-30 2006-09-29 Antibody composition against interleukin-13
CA2623429A CA2623429C (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
CN 201010551201 CN102060925B (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
GB0619204A GB2430883B (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
KR1020087010374A KR101363777B1 (en) 2005-09-30 2006-09-29 Interleukin-13 Antibody Composition
PCT/GB2006/003650 WO2007036745A2 (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
CN201410602375.5A CN104667275B (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
JP2008532878A JP2009510046A (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
BRPI0616359A BRPI0616359B8 (en) 2005-09-30 2006-09-29 PHARMACEUTICAL COMPOSITION, PROCESS FOR PURIFICATION OF AN IL-13 ANTIBODY AND USE OF A PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIBODY
SI200632277T SI1942939T2 (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
HUE06794604A HUE039022T2 (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
US12/067,120 US20080248048A1 (en) 2005-09-30 2006-09-29 Interleukin-13 Antibody Composition
NZ566694A NZ566694A (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition comprising an acetate buffer
PL06794604T PL1942939T5 (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
AU2006296399A AU2006296399B2 (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
PT06794604T PT1942939T (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
LTEP06794604.6T LT1942939T (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
DK06794604.6T DK1942939T4 (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
EP06794604.6A EP1942939B2 (en) 2005-09-30 2006-09-29 Interleukin-13 antibody composition
IL189983A IL189983A (en) 2005-09-30 2008-03-06 Process for purifying an interleukin-13 antibody and use of a pharmaceutical antibody composition in the manufacture of medicaments for the treatment of il-13 related disorders
ZA200802413A ZA200802413B (en) 2005-09-30 2008-03-14 Interleukin-13 antibody composition
NO20081946A NO344859B1 (en) 2005-09-30 2008-04-23 A pharmaceutical composition comprising an interleukin-13 antibody, a method of purifying an interleukin-13 antibody and using the pharmaceutical antibody composition
US12/966,377 US9107945B2 (en) 2005-09-30 2010-12-13 Methods of purifying anti-interleukin-13 antibodies
JP2013212846A JP5820450B2 (en) 2005-09-30 2013-10-10 Interleukin-13 antibody composition
IL230005A IL230005A (en) 2005-09-30 2013-12-17 Interleukin-13 antibody composition
US14/798,685 US10358488B2 (en) 2005-09-30 2015-07-14 Anti-interleukin-13 antibody compositions
HK15111703.8A HK1210724A1 (en) 2005-09-30 2015-11-27 Interleukin-13 antibody composition 13
IL246674A IL246674B (en) 2005-09-30 2016-07-10 Interleukin-13 antibody composition
CY181100758T CY1120874T1 (en) 2005-09-30 2018-07-20 INTERLEUKIN ANTIBODY SYNTHESIS-13
NL301143C NL301143I2 (en) 2005-09-30 2021-11-03 Tralokinumab
NO2021050C NO2021050I1 (en) 2005-09-30 2021-11-12 tralokinumab
FR21C1055C FR21C1055I2 (en) 2005-09-30 2021-11-16 COMPOSITION COMPRISING AN ANTI-INTERLEUKIN 13 ANTIBODY
LTPA2021528C LTPA2021528I1 (en) 2005-09-30 2021-11-17
FIC20210042C FIC20210042I1 (en) 2005-09-30 2021-11-23 Tralokinumab
HUS2100053C HUS2100053I1 (en) 2005-09-30 2021-12-02 Interleukin-13 antibody composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0519923.7A GB0519923D0 (en) 2005-09-30 2005-09-30 Interleukin-13 antibody composition

Publications (1)

Publication Number Publication Date
GB0519923D0 true GB0519923D0 (en) 2005-11-09

Family

ID=35395037

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0519923.7A Ceased GB0519923D0 (en) 2005-09-30 2005-09-30 Interleukin-13 antibody composition

Country Status (9)

Country Link
CN (3) CN102060925B (en)
DK (1) DK1942939T4 (en)
ES (1) ES2685440T5 (en)
GB (1) GB0519923D0 (en)
HU (1) HUE039022T2 (en)
LT (1) LT1942939T (en)
NZ (1) NZ566694A (en)
PT (1) PT1942939T (en)
ZA (1) ZA200802413B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0519923D0 (en) * 2005-09-30 2005-11-09 Cambridge Antibody Tech Interleukin-13 antibody composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248260A1 (en) * 2001-10-26 2004-12-09 Heavner George A. IL-13 mutein proteins, antibodies, compositions, methods and uses
US20040234499A1 (en) * 2001-10-26 2004-11-25 David Shealy Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
GB0519923D0 (en) * 2005-09-30 2005-11-09 Cambridge Antibody Tech Interleukin-13 antibody composition

Also Published As

Publication number Publication date
ES2685440T5 (en) 2021-11-30
CN104667275B (en) 2019-01-18
CN104667275A (en) 2015-06-03
PT1942939T (en) 2018-10-12
DK1942939T4 (en) 2021-09-13
LT1942939T (en) 2018-08-10
ES2685440T3 (en) 2018-10-09
HUE039022T2 (en) 2018-12-28
CN102060925A (en) 2011-05-18
ZA200802413B (en) 2009-05-27
NZ566694A (en) 2012-03-30
CN102060925B (en) 2013-05-08
CN101321540A (en) 2008-12-10
DK1942939T3 (en) 2018-08-20

Similar Documents

Publication Publication Date Title
HUS2100053I1 (en) Interleukin-13 antibody composition
HK1218126A1 (en) Anti-ilt7 antibody ilt7
IL185380A0 (en) ANTI-MAdCAM ANTIBODY COMPOSITIONS
IL187106A (en) Sclerostin-binding antibody
IL190472A0 (en) Anti-glypican-3 antibody
GB0503546D0 (en) Antibody
EP1930012A4 (en) Cellooligosaccharide-containing composition
EP1865042A4 (en) Frost-preventive composition
EP1847249A4 (en) Hairdye composition
EP1947129A4 (en) Photoradial- and photocation-curable composition
EP1864573A4 (en) Agricultural-chemical composition
PL1871804T3 (en) Antibodies that bind ccx-ckr2
ZA200802413B (en) Interleukin-13 antibody composition
GB0500400D0 (en) Antibody

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)